Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-09-18
2007-09-18
Campell, Bruce (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C436S543000
Reexamination Certificate
active
10420196
ABSTRACT:
The invention provides derivatives of efavirenz and methods of making derivatives of efavirenz. The derivatives include immunogenic compounds for producing antibodies to efavirenz and labeled efavirenz tracers. These compounds are useful in immunoassay methods for determining efavirenz.
REFERENCES:
patent: 5519021 (1996-05-01), Young et al.
patent: 2003/0100088 (2003-05-01), Sigler et al.
patent: WO 90/15798 (1990-12-01), None
patent: WO 96/37457 (1996-11-01), None
patent: WO 99/64048 (1999-12-01), None
patent: WO 03/006506 (2003-01-01), None
Maurin et al. Kinetics and Mechanism of Hydrolysis of Efavirenz. Pharmaceutical Research, vol. 19, No. 4, Apr. 2002, pp. 517-521.
Chemical Antibodies, AAL Reference Laboratories, Inc. Nov. 13, 1997, 5 pages.
Exercise 3, Antigen-Antibody I; LSMUC and the Department of Microbiology, Immunology and Parasitology, 1995, 5 pages.
Harlow et al. Antibodies: A Laboratory Manual. 1998, pp. 72 and 131.
Azoulay et al. Immunosassay, a simple and efficient method for plasmatic and intracellular quantification of antiviral drugs. Sixth International Congress of Drug Therapy in HIV infection, Abstract No. P193. Nov. 17-21, 2002.
Marzolini, Catia et al., “Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients,” AIDS 2001, vol. 15, No. 1, pp. 71-75.
Mutlib, A.E. et al., “Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz,” Drug Metabolism and Disposition, vol. 27, No. 11, 1319-1333, 1999.
Rezk, Naser L. et al., “Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection,” Journal of Chromatography B, 774 (200) 79-88.
Arabshahi Lili
Ghoshal Mitali
Sigler Gerald F.
Amick Marilyn L.
Campell Bruce
Le Emily M.
Roche Diagnostics Operations Inc.
Roche Diagnostics Operations Inc.
LandOfFree
Reagents for detecting efavirenz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents for detecting efavirenz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents for detecting efavirenz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776756